VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DCBO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DCBODocebo Inc.
$23.33$592M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDCBOBalance Sheet

Docebo Inc. (DCBO) Balance Sheet

9Y historyFree accessUpdated daily

The balance sheet has been fundamentally restructured, with total debt surging from $4.5M to $93.8M in two quarters, resulting in negative shareholders' equity of -$306K and a current ratio that has fallen to 0.83.

Income StatementBalance SheetCash FlowRatios

DCBO Balance Sheet

Annual statement

DCBO Balance Sheet

Docebo Inc. (DCBO) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets120.36M141.57M154.24M127.15M263.58M251.59M238.39M58.94M11.64M8.41M
Cash & Short-Term Investments45.72M73.9M92.58M72.03M216.47M215.42M219.66M46.28M3.76M3.36M
Cash Only45.72M73.9M92.54M71.95M216.29M215.32M219.66M46.28M3.76M3.36M
Short-Term Investments0043K83K174K99K0000
Accounts Receivable54.95M55.99M45.6M42.74M37.96M27.78M15.79M10.2M6.14M4.41M
Days Sales Outstanding74.4284.2176.7386.2696.9697.2891.689.8382.7593.95
Inventory0000000000
Days Inventory Outstanding----------
Other Current Assets10.33M11.68M7.45M6.39M2.78M1.39M2.94M605K243K0
Total Non-Current Assets122.36M64.7M36.47M31.22M20.08M16.63M16.64M4.92M1.66M1.09M
Property, Plant & Equipment7.49M4.42M3.13M3.45M4.66M5.7M5.09M3.9M1.29M1.09M
Fixed Asset Turnover44.45x54.86x69.22x52.42x30.65x18.28x12.37x10.63x21.05x15.65x
Goodwill53.67M14.51M13.85M14.25M5.98M5.3M5.6M000
Intangible Assets23.66M1.03M1.67M2.4M1.15M1.58M2.1M000
Long-Term Investments00045K241K204K270K324K00
Other Non-Current Assets17.1M24.75M12.61M10.75M7.93M3.85M2.8M698K375.21K0
Total Assets242.72M206.27M190.71M158.38M283.67M268.22M255.03M63.86M13.3M9.5M
Asset Turnover1.18x1.18x1.14x1.14x0.50x0.39x0.25x0.65x2.04x1.80x
Asset Growth %78.07%8.16%20.42%-44.17%5.76%5.17%299.35%380.12%39.97%-
Total Current Liabilities145.51M123.57M128.6M100.65M84.36M69.27M45.73M28.54M24.89M11.46M
Accounts Payable40.62M35.89M34.86M31.66M26.02M22.85M16.12M9.59M6.78M3.83M
Days Payables Outstanding266.34273.8308.13335337.11401.26509.94418.41438.22320.91
Short-Term Debt0619.87K00001.27M20K5.36M20.35K
Deferred Revenue (Current)359.18M85.31M72.92M67.27M55.78M44.58M28.33M18M12.69M7.58M
Other Current Liabilities3.52M785.57K18.3M01.08M467K0054.71K35.07K
Current Ratio0.83x1.15x1.20x1.26x3.12x3.63x5.21x2.07x0.47x0.73x
Quick Ratio0.83x1.15x1.20x1.26x3.12x3.63x5.21x2.07x0.47x0.73x
Cash Conversion Cycle-191.92---------
Total Non-Current Liabilities97.51M8.74M4.35M7M7.1M8.29M8.99M3.94M5.19M4.19M
Long-Term Debt87.95M1.94M0000016K4.02M3.32M
Capital Lease Obligations11.16M1.94M154K639K1.69M2.69M2.54M2.48M00
Deferred Tax Liabilities3M661.79K29K1.42M1.28M692K1.49M000
Other Non-Current Liabilities2.75M1.65M3.37M4.33M3.6M4.8M4.96M1.44M1.17M871.71K
Total Liabilities243.02M132.31M132.95M107.65M91.46M77.57M54.72M32.48M30.08M15.66M
Total Debt93.77M4.49M1.5M2.11M3.07M4M3.82M3.45M9.38M3.34M
Net Debt48.05M-69.41M-91.05M-69.84M-213.23M-211.32M-215.84M-42.83M5.62M-17.92K
Debt / Equity-306.43x0.06x0.03x0.04x0.02x0.02x0.02x0.11x--
Debt / EBITDA3.34x0.16x0.07x-0.47x-----
Net Debt / EBITDA1.71x-2.51x-4.08x--32.71x-----
Interest Coverage10.42x168.43x107.28x17.29x29.29x-30.42x-15.40x-12.96x--46.68x
Total Equity-306K73.96M57.76M50.72M192.21M190.66M200.31M31.38M-16.78M-6.16M
Equity Growth %-173.62%28.04%13.88%-73.61%0.82%-4.82%538.3%287.06%-172.53%-
Book Value per Share-0.012.521.871.515.655.806.921.29-0.56-0.20
Total Shareholders' Equity-306K73.96M57.76M50.72M192.21M190.66M200.31M31.38M-16.78M-5.1M
Common Stock212.78M244.16M253.29M247.5M268.19M266.12M264.36M89.75M30.72M9.96M
Retained Earnings-230.47M-183.7M-205.37M-204.79M-74.87M-81.89M-68.29M-60.27M-48.32M-14.86M
Treasury Stock0000000000
Accumulated OCI-5.26M-7.41M-9.28M-5.95M-9.57M2.11M1.7M805K262.56K-514.8K
Minority Interest000000000-1.05M

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Leverage spike from M&A and buybacks

Leverage Spike from Strategic Shift

Docebo's balance sheet has undergone a dramatic transformation, with total debt surging from $4.5M in 2025Q4 to $93.8M in 2026Q2, while equity turned negative, signaling a major strategic pivot towards inorganic growth and shareholder returns funded by debt.

The shift from a net cash position to significant leverage appears to be a deliberate strategic choice, likely to fund the acquisitions and share repurchases noted in the cash flow analysis. This has fundamentally altered the company's risk profile, moving it from a conservative, asset-light model to one with meaningful financial obligations. The negative equity position, driven by accumulated deficits and the new debt, suggests the company is now operating with a highly leveraged capital structure.

Newly Formed Debt Burden

According to recent SEC filings, Docebo's total debt has ballooned to $93.8M as of 2026Q2, a stark contrast to the near-debt-free position held just two quarters prior, indicating a significant increase in financial risk and interest expense obligations.

The rapid accumulation of debt, without a corresponding increase in equity, has pushed the company into a negative equity position. This leverage appears to be necessity-driven to finance the strategic activities mentioned in the cash flow analysis, rather than a strategic choice to optimize a low cost of capital. The lack of a reported D/E ratio in recent quarters, due to negative equity, underscores the severity of this shift and warrants close monitoring of debt covenants and refinancing risk.

Cash Position Eroded by Strategic Deployment

Based on reported figures, Docebo's cash reserves have declined from $92.5M in 2024Q4 to $45.7M in 2026Q2, while the current ratio has fallen below 1.0, suggesting a tightening liquidity position that may constrain operational flexibility.

The erosion of the cash buffer, combined with the new debt load, has significantly reduced the company's financial cushion. The current ratio falling to 0.83 indicates that current liabilities now exceed current assets, a potential red flag for short-term solvency if not managed carefully. This liquidity profile appears to be a direct consequence of the aggressive capital deployment strategy, leaving less room for operational missteps or unexpected cash needs.

Goodwill Dominance and Asset Quality Shift

As reported in financial statements, goodwill has surged from $14.5M in 2025Q4 to $53.7M in 2026Q2, now representing over 22% of total assets, which may indicate significant acquisition activity and introduces potential impairment risk.

The dramatic increase in goodwill, coinciding with the debt spike, strongly suggests the recent M&A activity was funded by the new borrowings. This concentration of value in intangible assets makes the balance sheet more vulnerable to future write-downs if acquired businesses underperform. Meanwhile, the modest growth in PPE suggests the core business remains asset-light, but the overall asset quality is now heavily dependent on the successful integration and performance of acquired entities.

Negative Equity from Accumulated Deficits

Docebo's shareholders' equity has turned negative, standing at -$306K in 2026Q2, driven by a cumulative retained earnings deficit of $230.5M and the recent debt-funded capital returns, signaling a balance sheet under significant strain.

The negative equity position is a critical development, indicating that the company's accumulated losses and recent capital distributions now exceed its asset base. This is not a sustainable long-term structure and may limit future financing options or increase the cost of capital. The trend suggests that the company's historical growth has been funded by equity and now debt, without yet generating sufficient cumulative profits to build a positive equity buffer.

Deferred Revenue as a Hidden Liability

A key non-obvious risk is the substantial deferred revenue balance of $96.3M in 2026Q2, which represents a significant future performance obligation that could pressure cash flow if customer renewals or new business slows.

While deferred revenue is a normal part of SaaS accounting, its magnitude relative to the company's tightened liquidity position is noteworthy. This balance represents cash already collected for services yet to be delivered, creating a future liability. If business growth decelerates further, as suggested by the income statement analysis, the company may face pressure to fulfill these obligations without the corresponding future cash inflows, potentially exacerbating the liquidity strain.

DCBO — Frequently Asked Questions

Quick answers to the most common questions about buying DCBO stock.

What are the total assets of Docebo Inc. (DCBO)?

As of 2025, Docebo Inc. (DCBO) had total assets of $206.3M including $141.6M in current assets.

How much debt does Docebo Inc. (DCBO) have?

Docebo Inc. (DCBO) carries total debt of $4.5M, offset by $73.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Docebo Inc.?

Docebo Inc. (DCBO) has total shareholders' equity (book value) of $74.0M ($2.52 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Docebo Inc.'s current ratio and liquidity?

Docebo Inc. (DCBO) reported a current ratio of 1.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.